[1]
“PLASMALYTE IN MUSCULOSKELETAL DISORDERS: IMPLICATIONS FOR THE MANAGEMENT OF DORSALGI”, jmsi, vol. 4, no. 8, pp. 352–355, Sep. 2025, doi: 10.55640/.